Results 131 to 140 of about 38,942 (318)

The efficacy of ranibizumab treatment in clinical practice in patients with the wet form of age-related macular degeneration. The results of the Czech National Registry

Biomedical Papers, 2015
Aims: The aim of this communication was to evaluate ranibizumab in the treatment of wet age-related macular degeneration. Methods: Anonymised data on treatment efficacy and safety were consecutively entered into the Czech national database.
Oldrich Chrapek, Jiri Jarkovsky, Jan Studnicka, Martin Sin, Petr Kolar, Barbora Jirkova, Ladislav Dusek, Sarka Pitrova, Jiri Rehak   +8 more
doaj   +1 more source

A Preterm Infant With Gestational Age of 21+4 Weeks

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT We report a case of a male infant who was conceived through in vitro fertilization, with a gestational age of 21+4 weeks. The infant was discharged home at 42 weeks' postmenstrual age without significant cranial morbidities.
Haifeng Zong, Bingchun Lin, Yingsui Huang, Shan Jiang, Yurong Yuan, Xiaoyuan Xiong, Zhichun Feng, Chuanzhong Yang   +7 more
wiley   +1 more source

A pilot study of intralesional ranibizumab on pterygium vascularity, size and recurrence rate [PDF]

, 2015
Introduction: Pterygium is a common eye disorder in Malaysia due to the country’s location near to the equator. Recent study has found that vascular endothelial growth factor (VEGF) is present in great amount in pterygium epithelium especially in its ...
Chi, Ho Hao
core  

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration. [PDF]

, 2008
PURPOSE: To determine the incidence of and the risk factors for the development of retinal pigment epithelial (RPE) tears after intravitreal bevacizumab (Avastin) injection for the treatment of exudative age-related macular degeneration (AMD). METHODS: A
Brod, Roy, Fischer, David, Garg, Sunir, Kim, David, Lane, R Gary, Maguire, Joseph   +5 more
core   +2 more sources

Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab

Clinical Ophthalmology, 2011
Christina Antonopoulos1, Maxwell Stem2, Grant M Comer21Department of Ophthalmology, Boston University, Boston, MA, USA; 2WK Kellogg Eye Center, Department of Ophthalmology, University of Michigan, Ann Arbor, MI, USAPurpose: Previous reports have ...
Antonopoulos C, Stem M, Comer GM
doaj  

A simulation tool for better management of retinal services [PDF]

, 2018
Background: Advances in the management of retinal diseases have been fast-paced as new treatments become available, resulting in increasing numbers of patients receiving treatment in hospital retinal services.
A Kotecha, A Kotecha, Aimee Verner, Andriy Danyliv, CG Owen, David Southern, Eren Demir, FG Holz, GA Lalwani, HR Wright, JA Haller, K Hatz, Karsten Kortuem, Katja Hatz, KT Tsaousis, Line Kvannli, OP Gupta, RB Rush, S Trikha, W Amoaku, Winfried Amoaku   +20 more
core   +2 more sources

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration

Clinical Ophthalmology, 2012
Patrick D Williams,1 David Callanan,1 Wayne Solley,1 Robert L Avery,2 Dante J Pieramici,2 Tom Aaberg31Texas Retina Associates, Dallas, TX, 2California Retina Consultants and Research Foundation, Santa Barbara, CA, 3Retinal Associates, Grand Rapids, MI ...
Williams PD, Callanan D, Solley W, Avery RL, Pieramici DJ, Aaberg T   +5 more
doaj  

Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys.

PLoS ONE, 2014
PurposeIt is known that endothelial cells in the kidney are also strongly VEGF-dependent. Whether intravitreal drugs can be detected within the glomeruli or affect VEGF in glomerular podocytes is not known.
Alexander Tschulakow, Sarah Christner, Sylvie Julien, Maximilian Ludinsky, Markus van der Giet, Ulrich Schraermeyer   +5 more
doaj   +1 more source

Missed Hospital Appointments of Patients Receiving Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration [PDF]

, 2015
INTRODUCTION: The aim of this study was to investigate the frequency and duration of missed hospital appointments (MHAs) in a consecutive cohort of patients treated with ranibizumab for neovascular age-related macular degeneration (nAMD) and to assess ...
Aachal Kotecha, Angela Rees, Eleni Nikita, Maria Pefkianaki, Michael Karampelas, Navdeep Gill, Praveen J. Patel, Robin Hamilton   +7 more
core   +1 more source

Comparative study between ranibizumab and aflibercept in the management of macular edema caused by diabetes mellitus in age group more than 40 years

Al-Azhar Assiut Medical Journal, 2019
Background Diabetic macular edema (DME) is a common cause of blindness and visual impairment in diabetic patients, which can affect the quality of life.
Abd El-Magid M Tag El-Din
doaj   +1 more source